NOTICE AND PROXY STATEMENT

Company

Lineage Cell Therapeutics, Inc.

Filed

November 3, 2003

Period of Report

December 5, 2003

Accession Number

0000950005-03-001027

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →